brentuximab vedotin,rituximab,ibrutinib,Bendamustine
Seagen,Takeda,biogen,roche,novartis,janssen,abbvie
['lcsm,(-blcsm)', 'lymsm', 'sclc', 'nsclc', 'shine']
day 1 #asco22 highlights #communityoncology perspective 1. pooled analysis for mnsclc, ici vs. chemo + ici by 2. outcomes of 1l krasm nsclc 3. #echelon1 update 4. launch of asco med cop 5. #shine - 1l mcl #lcsm #meded #medtwitter #lymsm 1/6
Practice changing #Oncology news from #CommunityOncologists perspective w/ Rohit Gosain @UPMCHillmanCC & Rahul Gosain @GuthrieClinic. Views are our own.